KeyBanc Capital Markets analyst Paul Knight downgraded Thermo Fisher Scientific Inc (NYSE:TMO) to Sector Weight from Overweight.
Yesterday, TMO posted Q3 revenue of $10.574 billion, down 1% Y/Y, missing the consensus of $10.595 billion. Adjusted EPS of $5.69 beat the consensus of $5.61.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased